{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "MXN", "exchange": "MEX", "shortName": "2SEVENTY BIO INC", "longName": "2seventy bio, Inc.", "messageBoardId": "finmb_700837637", "market": "mx_market", "marketState": "PREPRE", "earningsTimestamp": 1683145800, "earningsTimestampStart": 1683145800, "earningsTimestampEnd": 1683145800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -127.65, "sharesOutstanding": 50199300, "bookValue": 8.186, "fiftyDayAverage": 172.34, "fiftyDayAverageChange": -2.3399963, "fiftyDayAverageChangePercent": -0.01357779, "twoHundredDayAverage": 274.055, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "America/Mexico_City", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": -21600000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 170.0, "regularMarketChange": 0.0, "regularMarketTime": 1683315347, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 0, "regularMarketPreviousClose": 170.0, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Mexico", "financialCurrency": "USD", "regularMarketOpen": 0.0, "averageDailyVolume3Month": 9, "averageDailyVolume10Day": 11, "fiftyTwoWeekLowChange": 170.0, "fiftyTwoWeekRange": "0.0 - 553.0", "fiftyTwoWeekHighChange": -383.0, "fiftyTwoWeekHighChangePercent": -0.6925859, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 553.0, "twoHundredDayAverageChange": -104.05499, "twoHundredDayAverageChangePercent": -0.37968653, "marketCap": 10519242752, "priceToBook": 20.767164, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "firstTradeDateMilliseconds": 1636554600000, "priceHint": 2, "symbol": "TSVT.MX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "60 Binney Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "339 499 9300", "website": "https://www.2seventybio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 425, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nick  Leschly", "age": 49, "title": "Pres, CEO & Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 1811892, "fmt": "1.81M", "longFmt": "1,811,892"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Philip D. Gregory D. Phil., DPHIL", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 1013261, "fmt": "1.01M", "longFmt": "1,013,261"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. William D. Baird III, M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  Abu-Absi Ph.D.", "title": "Chief Technology & Manufacturing Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Teresa L. Jurgensen J.D.", "title": "Sr. VP, Gen. Counsel & Corp. Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kathleen A. Wilkinson", "age": 50, "title": "Chief People Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jenn  Snyder", "title": "Sr. VP of Corp. Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Steven  Bernstein M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Melissa  Price Ph.D.", "age": 48, "title": "Sr. VP of Devel. Operations & Portfolio Strategy", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}